These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8033098

  • 1. Reduction of intratumoral pH by the mitochondrial inhibitor m-iodobenzylguanidine and moderate hyperglycemia.
    Kuin A, Smets L, Volk T, Paans A, Adams G, Atema A, Jähde E, Maas A, Rajewsky MF, Visser G.
    Cancer Res; 1994 Jul 15; 54(14):3785-92. PubMed ID: 8033098
    [Abstract] [Full Text] [Related]

  • 2. pH in human tumor xenografts and transplanted rat tumors: effect of insulin, inorganic phosphate, and m-iodobenzylguanidine.
    Jähde E, Volk T, Atema A, Smets LA, Glüsenkamp KH, Rajewsky MF.
    Cancer Res; 1992 Nov 15; 52(22):6209-15. PubMed ID: 1423263
    [Abstract] [Full Text] [Related]

  • 3. Intracellular acidification of human melanoma xenografts by the respiratory inhibitor m-iodobenzylguanidine plus hyperglycemia: a 31P magnetic resonance spectroscopy study.
    Zhou R, Bansal N, Leeper DB, Glickson JD.
    Cancer Res; 2000 Jul 01; 60(13):3532-6. PubMed ID: 10910065
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
    Aboagye EO, Dillehay LE, Bhujwalla ZM, Lee DJ.
    Radiat Oncol Investig; 1998 Jul 01; 6(6):249-54. PubMed ID: 9885940
    [Abstract] [Full Text] [Related]

  • 7. Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH.
    Gabr A, Kuin A, Aalders M, El-Gawly H, Smets LA.
    Cancer Res; 1997 Nov 01; 57(21):4811-6. PubMed ID: 9354443
    [Abstract] [Full Text] [Related]

  • 8. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
    Sakamoto N, Toge T, Nishiyama M.
    Hiroshima J Med Sci; 1997 Jun 01; 46(2):67-73. PubMed ID: 9232934
    [Abstract] [Full Text] [Related]

  • 9. FSaII mouse tumor metabolic changes with different doses of glucose measured by 31P nuclear magnetic resonance.
    Koutcher JA, Fellenz MP, Vaupel PW, Gerweck LE.
    Cancer Res; 1988 Nov 01; 48(21):5917-21. PubMed ID: 3139286
    [Abstract] [Full Text] [Related]

  • 10. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    J Nucl Med; 1995 Apr 01; 36(4):644-50. PubMed ID: 7699460
    [Abstract] [Full Text] [Related]

  • 11. Tumor-selective modification of cellular microenvironment in vivo: effect of glucose infusion on the pH in normal and malignant rat tissues.
    Jähde E, Rajewsky MF.
    Cancer Res; 1982 Apr 01; 42(4):1505-12. PubMed ID: 7060023
    [Abstract] [Full Text] [Related]

  • 12. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I, Hasmann M, Saltz LB, Koutcher JA.
    Clin Cancer Res; 2005 May 01; 11(9):3503-13. PubMed ID: 15867253
    [Abstract] [Full Text] [Related]

  • 13. Utility of positron emission tomography in sarcomas.
    Schuetze SM.
    Curr Opin Oncol; 2006 Jul 01; 18(4):369-73. PubMed ID: 16721133
    [Abstract] [Full Text] [Related]

  • 14. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK.
    Clin Cancer Res; 2000 Apr 01; 6(4):1498-507. PubMed ID: 10778982
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of antitumor effect of hyperthermia with glucose administration in murine mammary carcinoma.
    Akagi K, Aoki Y, Nasu R, Nagata K, Itagaki Y, Sawada S.
    Oncol Rep; 1999 Apr 01; 6(3):593-6. PubMed ID: 10203597
    [Abstract] [Full Text] [Related]

  • 16. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice.
    Podo F, Carpinelli G, Di Vito M, Giannini M, Proietti E, Fiers W, Gresser I, Belardelli F.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6481-9. PubMed ID: 3677088
    [Abstract] [Full Text] [Related]

  • 17. Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal by respiratory inhibitors.
    Burd R, Wachsberger PR, Biaglow JE, Wahl ML, Lee I, Leeper DB.
    Cancer Res; 2001 Jul 15; 61(14):5630-5. PubMed ID: 11454717
    [Abstract] [Full Text] [Related]

  • 18. Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy.
    Singer S, Neuringer LJ, Thilly WG, Chen LB.
    Cancer Res; 1993 Dec 01; 53(23):5808-14. PubMed ID: 8242640
    [Abstract] [Full Text] [Related]

  • 19. [Hydrogen ion concentration in tumor issue and artificial hyperglycemia].
    Osinskiĭ SP, Bubnovskaia LN.
    Eksp Onkol; 1985 Dec 01; 7(5):3-7. PubMed ID: 3905356
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H, Tassini M, Vivi A, Navon G, Kaplan O.
    Cancer Res; 1995 Jul 01; 55(13):2814-21. PubMed ID: 7796408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.